CDK5 and ovarian carcinoma: So far, no further data regarding the correlation between Cdk5 and dinaciclib sensitivity is available; however some studies have revealed that an increased expression of Cdk5 is more likely to be associated with chemo-resistance, whereas a lower expression is more likely to be associated with increased sensitivity to chemotherapy in ovarian cancer.17